Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Atomoxetine and tics in ADHD

Peter D Feldman, Dustin D Ruff, Albert J Allen

    Journal of the American Academy of Child and Adolescent Psychiatry
    |April 22, 2005
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Requirements and special considerations for drug trials with children across six jurisdictions: 1. Clinical trial application review in the regulatory approval process.

    Frontiers in medicine·2025
    Same author

    Requirements and special considerations for drug trials with children across six jurisdictions: 2. Ethics review in the regulatory approval process.

    Frontiers in medicine·2025
    Same author

    Monitoring Pregnancies Exposed to Galcanezumab for Migraine in a United States Administrative Claims Database.

    Pharmacoepidemiology and drug safety·2024
    Same author

    Establishing a global regulatory floor for children's decisions about participation in clinical research.

    Pediatric research·2023
    Same author

    Migraine Headache Day Response Rates and the Implications to Patient Functioning: An Evaluation of 3 Randomized Phase 3 Clinical Trials of Galcanezumab in Patients With Migraine.

    Headache·2020
    Same author

    Medication overuse in a subgroup analysis of phase 3 placebo-controlled studies of galcanezumab in the prevention of episodic and chronic migraine.

    Cephalalgia : an international journal of headache·2020